Assessing single joints in arthritis clinical trials

Journal of Rheumatology

Volumn 36, Issue 9, 2009, Pages 2092-2096

  Keen, Helen I ^a   Bingham III, Clifton O ^b   Bradley, Laurence A ^c   Conaghan, Philip G ^d   Heald, Alison E ^e   Kaeley, Gurjit S ^f   Maksymowych, Walter P ^g   Moskowitz, Roland W ^h   Schumacher Jr , H Ralph ⁱ   Woodworth, Thasia E ^j   Mease, Philip J ^k,l  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e Targeted Genetics Corporation   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF ALBERTA   (Canada)

^h UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j ROCHE PRODUCTS LTD   (United Kingdom)

^k Seattle Rhumatology Associates   (United States)

^l UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Joint examination; Knee arthritis; Outcome assessment; Reliability; Responsiveness; Validity

Indexed keywords

ADALIMUMAB; OPIATE; PARVOVIRUS VECTOR; STEROID; TUMOR NECROSIS FACTOR RECEPTOR; YTTRIUM 90;

CONFERENCE PAPER; CONSTRUCT VALIDITY; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; GOUT; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; KNEE ARTHRITIS; KNEE OSTEOARTHRITIS; OUTCOME ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; VIRAL GENE THERAPY; VISUAL ANALOG SCALE;

ARTHRITIS; HUMANS; KNEE JOINT; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCIBILITY OF RESULTS;

EID: 70349262567     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090364     Document Type: Conference Paper

References (10)

1. van Riel PL, van Gestel AM, van de Putte LB. Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br J Rheumatol 1996;35:4-7. (Pubitemid 26297361)
2. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-735
3. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-199
4. Giles JT, Mease P, Boers M, et al. Assessing single joints in arthritis clinical trials. J Rheumatol 2007;34:641-647 (Pubitemid 46364024)
5. Mease PJ, Hobbs K, Chalmers A, et al. Local delivery of a recombinant adeno-associated vector containing a tumor necrosis factor-alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study. Ann Rheum Dis 2008;Aug 4 E-pub.
6. Schumacher HR, Taylor W, Edwards L, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol 2009;36: [in press].
7. Grainger R, Taylor W, Dalbeth N, et al. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol 2009;36: [in press].
8. Bradley LA, Kersh BC, DeBerry JJ, Deutsch G, Alarcon GA, McLain DA. Lessons from fibromyalgia: abnormal pain sensitivity in knee osteoarthritis. Novartis Foundation Symp 2004;260:258-270 (Pubitemid 41322997)
9. Edwards RR, Doleys DM, Fillingim RB, Lowery D. Ethnic differences in pain tolerance: clinical implications in a chronic pain population. Psychosom Med 2001;63:316-323 (Pubitemid 32249957)
10. Campbell CM, France CR, Robinson ME, Logan HC, Geffken GR, Fillingim RB. Ethnic differences in diffuse noxious inhibitory controls. J Pain 2008;9:759-766